TGDIX | VIVIX | TGDIX / VIVIX | |
Total Expense Ratio | 0.70 | 0.04 | 1,750% |
Annual Report Gross Expense Ratio | 0.77 | 0.04 | 1,925% |
Fund Existence | 21 years | 27 years | - |
Gain YTD | 1.801 | 2.452 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 444M | 189B | 0% |
Annual Yield % from dividends | 0.77 | 2.29 | 34% |
Returns for 1 year | 4.32 | 8.01 | 54% |
Returns for 3 years | 33.72 | 32.19 | 105% |
Returns for 5 years | 64.10 | 72.56 | 88% |
Returns for 10 years | -25.04 | 103.54 | -24% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRHSX | 77.13 | -0.37 | -0.48% |
T. Rowe Price Health Sciences | |||
VGREX | 6.92 | -0.06 | -0.86% |
VALIC Company I Global Real Estate | |||
RGSCX | 23.70 | -0.30 | -1.25% |
Virtus KAR Global Small-Cap C | |||
VKSRX | 19.85 | -0.29 | -1.44% |
Virtus KAR Small-Mid Cap Core R6 | |||
GSITX | 51.36 | -0.92 | -1.76% |
Goldman Sachs Small Cp Val Insghts Instl |